https://www.bioworld.com/rss en-us LDLR gene and characterized by severe hypercholesterolemia and premature cardiovascular disease. Repair Biotechnologies Inc. has developed REP-0003, a therapeutic based on the Cholesterol Degrading Platform (CDP) that degrades excessive intracellular free cholesterol into a non-toxic and excretable catabolite to safely reverse cholesterol-rich vulnerable plaque.]]> http://www.bioworld.com/articles/726524 Mon, 24 Nov 2025 08:00:00 -0500 https://www.bioworld.com/articles/726524-rep-0003-heals-liver-by-reducing-free-hepatic-cholesterol http://www.bioworld.com/articles/726410 Fri, 21 Nov 2025 08:00:00 -0500 https://www.bioworld.com/articles/726410-eikonizos-hdac6-inhibitor-improves-hfpef-pathology http://www.bioworld.com/articles/725962 Tue, 11 Nov 2025 11:00:00 -0500 https://www.bioworld.com/articles/725962-closure-af-study-not-the-end-of-the-line-for-laac-devices Boston Scientific Corp.’s Watchman Flx device Boston Scientific Corp.’s Watchman Flx device http://www.bioworld.com/articles/725961 Tue, 11 Nov 2025 11:00:00 -0500 https://www.bioworld.com/articles/725961-ocean-study-hints-at-no-need-for-doacs-after-afib-ablation Atrial fibrillation illustration http://www.bioworld.com/articles/726058 Tue, 11 Nov 2025 08:00:00 -0500 https://www.bioworld.com/articles/726058-monte-rosas-mrt-8102-suppresses-nlrp3-inflammasome-activation http://www.bioworld.com/articles/725951 Mon, 10 Nov 2025 11:00:00 -0500 https://www.bioworld.com/articles/725951-fish-and-chips-serves-up-appetizing-news-for-heartflow Heartflow FFRCT analysis Credit: Heartflow Inc. Heartflow FFRCT analysis Credit: Heartflow Inc. http://www.bioworld.com/articles/725950 Mon, 10 Nov 2025 11:00:00 -0500 https://www.bioworld.com/articles/725950-kestra-poised-to-make-headway-in-wearable-defibrillators Kestra Kestra Assure wearable cardioverter defibrillator. Credit: Kestra http://www.bioworld.com/articles/715030 Wed, 04 Dec 2024 09:00:00 -0500 https://www.bioworld.com/articles/715030-mtx-652-attenuates-tac-induced-cardiac-dysfunction-in-vivo Heart scientific overlay http://www.bioworld.com/articles/714930 Fri, 29 Nov 2024 09:00:00 -0500 https://www.bioworld.com/articles/714930-gpr39-blockade-prevents-hypoxia-induced-pulmonary-artery-hypertension Lungs and bronchi http://www.bioworld.com/articles/714914 Thu, 28 Nov 2024 09:00:00 -0500 https://www.bioworld.com/articles/714914-e-therapeutics-b4galt1-targeting-galomic-sirna-demonstrates-prolonged-duration-of-action Digital cardiology illustration http://www.bioworld.com/articles/714866 Wed, 27 Nov 2024 00:00:00 -0500 https://www.bioworld.com/articles/714866-hd1-12dma-dab-is-a-rapid-and-potent-anticoagulant-researchers-show Blood clot under microscope. Credit: Mark Ellisman and Thomas Deerinck, National Center for Microscopy and Imaging Research/University of California, San Diego/NIH http://www.bioworld.com/articles/714706 Thu, 21 Nov 2024 09:00:00 -0500 https://www.bioworld.com/articles/714706-etx-258-improves-cardiac-function-and-structural-remodeling-post-mi Human heart within crosshairs http://www.bioworld.com/articles/714697 Thu, 21 Nov 2024 09:00:00 -0500 https://www.bioworld.com/articles/714697-linoleic-acid-metabolite-reduces-atrial-arrhythmia-by-normalizing-camkii-levels http://www.bioworld.com/articles/714596 Wed, 20 Nov 2024 09:00:00 -0500 https://www.bioworld.com/articles/714596-edg-7500-reverses-nonobstructive-hypertrophic-cardiomyopathy-in-vivo Illustration of human heart with DNA structure background http://www.bioworld.com/articles/714258 Mon, 18 Nov 2024 11:00:00 -0500 https://www.bioworld.com/articles/714258-boston-sci-study-shows-watchman-flx-better-option-than-doac Boston Scientific Corp.’s Watchman Flx device Boston Scientific Corp.’s Watchman Flx device http://www.bioworld.com/articles/703017 Mon, 20 Nov 2023 09:00:00 -0500 https://www.bioworld.com/articles/703017-solbinsiran-sirna-is-tested-in-cardiovascular-disease-models Vascular system http://www.bioworld.com/articles/703009 Mon, 20 Nov 2023 09:00:00 -0500 https://www.bioworld.com/articles/703009-anti-cd47-brb-002-shows-activity-in-mouse-atherosclerosis-model http://www.bioworld.com/articles/702956 Thu, 16 Nov 2023 09:00:00 -0500 https://www.bioworld.com/articles/702956-crispr-therapeutics-products-produce-long-lasting-reductions-in-angptl3-and-lpa Illustration of red blood cells traveling in the arteries http://www.bioworld.com/articles/702948 Thu, 16 Nov 2023 09:00:00 -0500 https://www.bioworld.com/articles/702948-he4-and-ca-125-as-markers-of-diffuse-myocardial-fibrosis Colorful illustration of the heart http://www.bioworld.com/articles/702815 Tue, 14 Nov 2023 09:00:00 -0500 https://www.bioworld.com/articles/702815-nox2-inhibition-restrains-the-development-of-obesity-mediated-atrial-fibrillation Obesity and heart disease illustration http://www.bioworld.com/articles/691327 Tue, 08 Nov 2022 11:00:00 -0500 https://www.bioworld.com/articles/691327-conference-data-for-nov-8-2022-aha New England Journal of Medicine (NEJM) and presented at the American Heart Association Scientific Sessions 2020.]]> http://www.bioworld.com/articles/500311 Tue, 17 Nov 2020 13:00:00 -0500 https://www.bioworld.com/articles/500311-medtronic-cryoablation-beats-drug-therapy-in-atrial-fibrillation Product image Arctic Front Advance cardiac cryoballoon. Credit: Medtronic plc http://www.bioworld.com/articles/500229 Mon, 16 Nov 2020 11:00:00 -0500 https://www.bioworld.com/articles/500229-conference-data-for-nov-16-2020-aha http://www.bioworld.com/articles/431201 Mon, 18 Nov 2019 00:00:00 -0500 https://www.bioworld.com/articles/431201-analysts-react-to-ischemia-trial-with-at-least-one-seeing-reduction-in-stent-sales